FDA

2 Reasons Alnylam Stock Fell on a Landmark Drug Approval
2 Reasons Alnylam Stock Fell on a Landmark Drug Approval
Motley Fool
Alnylam
FDA
Onpattro
hATTR amyloidosis
Flag link:
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer
Xconomy
FDA
Opdivo
Bristol-Myers Squibb
small cell lung cancer
Flag link:
Just a few days after a stumble, FDA OKs 12-week dose for Eylea as Regeneron braces for Novartis attack
Just a few days after a stumble, FDA OKs 12-week dose for Eylea as Regeneron braces for Novartis attack
Endpoints
FDA
Eylea
Regeneron
Novartis
wet age-related macular degeneration
Flag link:
Is FDA doing enough to support medical device security?
Is FDA doing enough to support medical device security?
Healthcare IT News
devices
hacking
cybersecurity
FDA
Flag link:
Sun Pharma receives USFDA nod for ophthalmic solution used to treat dry eye disease
Sun Pharma receives USFDA nod for ophthalmic solution used to treat dry eye disease
Economic Times, India
Sun Pharma
FDA
India
dry eye disease
Cequa
Flag link:
Vertex cystic fibrosis drug gets expanded approval for use in infants
Vertex cystic fibrosis drug gets expanded approval for use in infants
Reuters
FDA
Vertex Pharmaceuticals
Kalydeco
infants
cystic fibrosis
Flag link:
US agency to rule on Tecentriq’s most important use
US agency to rule on Tecentriq’s most important use
EP Vantage
Roche
Tecentriq
non-squamous non-small cell lung cancer
FDA
Flag link:
FDA approves one-year contraceptive ring
FDA approves one-year contraceptive ring
Biopharma Dive
FDA
contraceptives
contraceptive ring
Annovera
TherapeuticsMD
Flag link:
After Alnylam’s solo maiden launch, here comes the tricky bit
After Alnylam’s solo maiden launch, here comes the tricky bit
EP Vantage
Alnylam
drug launches
FDA
RNAi
Patisiran
Onpattro
Flag link:
Gottlieb: FDA Approvals for Pediatric Devices Continue to Lag
Gottlieb: FDA Approvals for Pediatric Devices Continue to Lag
RAPS.org
devices
FDA
pediatrics
Scott Gottlieb
Flag link:
Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies
Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies
Fierce Pharma
Novartis
Roche
Xolair
FDA
food allergies
Flag link:
Racing Novartis on Eylea rival, the FDA trips up Regeneron at the finish line
Racing Novartis on Eylea rival, the FDA trips up Regeneron at the finish line
Endpoints
Regeneron
Eylea
Novartis
RTH258
wet age-related macular degeneration
FDA
Flag link:
3 Biotech Stocks With Major Catalysts Incoming
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
TG Therapeutics
Sangamo Therapeutics
Akcea Therapeutics
FDA
Waylivra
umbralisib
SB-913
Flag link:
Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals
Amicus Finally Wins FDA Nod, Will Price Fabry Drug Below Rivals
Xconomy
Fabry disease
FDA
Amicus Therapeutics
Galafold
Flag link:
Alnylam Prices First Gene Silencing Drug At $450,000 Per Patient, But Offers Money-Back Guarantee
Alnylam Prices First Gene Silencing Drug At $450,000 Per Patient, But Offers Money-Back Guarantee
Forbes
Alnylam
FDA
drug pricing
hATTR amyloidosis
Onpattro
Flag link:
FDA clears controversial fertility app to prevent pregnancy
FDA clears controversial fertility app to prevent pregnancy
Stat
FDA
digital health
devices
mobile apps
contraceptives
Natural Cycles
Flag link:
In first, FDA approves RNA interference drug from Alnylam
In first, FDA approves RNA interference drug from Alnylam
Biopharma Dive
Alnylam
RNAi
FDA
Patisiran
Onpattro
hATTR amyloidosis
Flag link:
Shire dodges pricing questions as lanadelumab’s big day nears
Shire dodges pricing questions as lanadelumab’s big day nears
EP Vantage
Takeda
HAE
lanadelumab
FDA
Flag link:
Ampio Pharma craters on FDA setback but plans to fight back
Ampio Pharma craters on FDA setback but plans to fight back
Fierce Biotech
Ampio Pharmaceuticals
FDA
clinical trials
osteoarthritis
Ampion
Flag link:
ASCO and Friends of Cancer Research Draft 5 Guidances for FDA
ASCO and Friends of Cancer Research Draft 5 Guidances for FDA
RAPS.org
ASCO
FDA
cancer
oncology
clinical trials
Friends of Cancer Research
Flag link:

Pages